BRCA2 and breast cancer: In a prospective study involving 71 BRCA2-mutated BC patients and 1550 sporadic BC patients, adjuvant endocrine treatment did not reduce the risk of death in the BRCA2-mutated group (HR = 2.05, 95% CI 1.07–3.91, P = 0.03) [65].